Cychlorphine is a newer synthetic opiate which is roughly 10 x stronger than illicit Fentanyls. The stronger potential for lethality for individuals using Cychlorphine places additional pressure on treatment programs and providers to support clients to engage in recovery. As the withdrawal symptoms for various opiates can be deadly, full person-centered treatment options must be considered to help enhance the client’s success. Medication assisted treatment (MAT) and medications to help clients living with opiate use disorder (MOUD) can be essential options and tools to help enhance a client’s recovery and promote long term success. Participants will be provided education regarding the development and current use of Cychlorphine. Participants will identify the symptoms associated with Cychlorphine use. Participants will identify various options for MAT and MOUD. Participants will identify the benefits for MAT and MOUD for clients who meet criteria for this level of care.
Learning objectives:
- Participants will identify the history and current use of Cychlorphine.
- Participants will identify the symptoms associated with Cychlorphine use.
- Participants will identify various treatment options for clients who may consider MAT or MOUD.
- Participants will identify the benefits and limitations of MAT and MOUD.
Notes:
This event is subject to priority registration. If you have a code, you may register yourself now. If you do not have a registration code, please add yourself to the waitlist. Any registration spots avilable after the priority registration period is over will be awarded on a first-come first-served basis for those on the waitlist.
If you have any questions about this event, please email learn@midsouth.ualr.edu.
This course has been approved by UA-Little Rock MidSOUTH as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #226778. UA-Little Rock MidSOUTH is responsible for all aspects of the programming.
Registration fee is FREE. Attendees will receive 2 CEU hours.
